Boehringer Ingelheim is a Germany-based pharmaceutical company that manufactures and commercializes prescription medicines and animal healthcare products.
Business Model:
Revenue: $23.3B
Employees: 10,001-999,999
Address: Binger Strasse 173
City: Ingelheim am Rhein
State: rhineland-palatinate
Zip: 55216
Country: DE
Boehringer Ingelheim is a Germany-based pharmaceutical company that manufactures and commercializes prescription medicines and animal healthcare products.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2020 | Proxygen | Grant | - |
9/2020 | Click Therapeutics | Funding Round | 500M |
7/2018 | MabVax Therapeutics | Post-IPO Equity | 11M |
11/2014 | Promethera Biosciences | Series C | 0 |
1/2020 | NBE-Therapeutics | Series C | 0 |
1/2018 | Greybox Solutions | Series A | - |
9/2020 | Click Therapeutics | Corporate Round | 500M |
9/2020 | Click Therapeutics | Funding Round | 0 |
7/2020 | Proxygen | Grant | - |
1/2020 | NBE-Therapeutics | Series C | 0 |
7/2018 | MabVax Therapeutics | Post-IPO Equity | 0 |
1/2018 | Greybox Solutions | Series A | - |
11/2014 | Promethera Biosciences | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
6/2022 | Trutino Biosciences | |
9/2021 | Abexxa Biologics | |
12/2020 | NBE-Therapeutics | |
12/2020 | Labor Dr. Merk &a; Kollegen | |
7/2020 | Global Stem cell Technology | |
5/2020 | Northern Biologics Inc. | |
7/2019 | Amal Therapeutics | |
3/2019 | ICD Therapeutics | |
9/2018 | Vira Therapeutics | |
1/2017 | Merial Limited |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|